Three routes have been identified triggering neuronal death under physiological and pathological conditions. Excess activation of ionotropic glutamate receptors cause influx and accumulation of Ca 2+ and Na + that result in rapid swelling and subsequent neuronal death within a few hours. The second route is caused by oxidative stress due to accumulation of reactive oxygen and nitrogen species. Apoptosis or programmed cell death that often occurs during developmental process has been coined as additional route to pathological neuronal death in the mature nervous system. Evidence is being accumulated that excitotoxicity, oxidative stress, and apoptosis propagate through distinctive and mutually exclusive signal transduction pathway and contribute to neuronal loss following hypoxic-ischemic brain injury. Thus, the therapeutic intervention of hypoxic-ischemic neuronal injury should be aimed to prevent excitotoxicity, oxidative stress, and apoptosis in a concerted way.
Introduction
Stroke occurs when local thrombosis, embolic particles, or the rupture of blood vessels interrupts the blood flow to the brain. While stroke is the third most common cause of death in most developed countries, it is ranked as the first leading cause of death and severe disability in Korea. Brain function is impaired immediately after the blood flow drops below one fourth of normal values. If the ischemic condition persists for a prolonged period of time, primary neuronal death appears rapidly in the core areas, and is accompanied by secondary death in the ischemic penumbra that slowly evolves subsequent to the activation of multiple death pathways; therefore, it has been targeted for therapeutic intervention. The first line of interventional therapy stems from findings that excitotoxicity underlies one of the leading causes of neuronal death following hypoxic-ischemic insults. Accordingly, antagonists of ionotropic glutamate receptors have been developed. These reduce hypoxic-ischemic brain injury in various animal models, and have been applied for clinical trial of ischemic stroke, but with little therapeutic efficacy to date. Free radicals are primarily produced during a period of reperfusion, and are believed to contribute to delayed neuronal death. Finally, several lines of evidence suggest that apoptosis, or programmed cell death, comprises a portion of ischemic neuronal death. It is conceivable to postulate that the therapeutic intervention of ischemic neuronal death likely involves an appropriate combination of neuroprotective drugs that are designed to prevent excitotoxicity, oxidative stress, and apoptosis.
Excitotoxicity
Glutamate mediates excitatory synaptic transmission through the activation of ionotropic glutamate receptors that are sensitive to NMDA (N-methyl-D-aspartate), AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), or kainate. This excitatory transmission mediates normal information processing and neuronal plasticity. An interrupted blood supply to the brain causes deprivation of oxygen and glucose that are utilized to produce energy. Impaired energy increases presynaptic glutamate release through membrane depolarization and the subsequent activation of the voltagegated Ca 2+ channel. It also interferes with the re-uptake of glutamate (primarily into astrocytes), which results in the abnormal accumulation of synaptic glutamate. Excess and sustained activation of the ionotropic glutamate receptors causes fulminant neuronal death, namely glutamate neurotoxicity or excitotoxicity.
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Ca

2+
-mediated fast excitotoxicity The pentameric NMDA receptors consist of the fundamental subunit NMDAR1 and modulatory subunits of NMDAR2A-2D (Hollmann and Heinemann, 1994; Sucher et al., 1996) . The heteromeric NMDA receptors are highly permeable to Ca . Since a brief (>3 min) activation of NMDA receptors is sufficient to trigger neuronal death, then the activation of NMDA receptors has been proposed as a primary cause of neuronal death after the focal cerebral ischemia that is accompanied by the transient (~30-60 min) elevation of extracellular glutamate (Benveniste et al., 1984; Takagi et al., 1993) . The Ca 2+ influx through NMDA receptors mediates the rapidly-triggered NMDA neurotoxicity, while Na + influx contributes to the swelling of the neuronal cell body (Choi, 1987) (Fig. 1) .
AMPA receptors consist of a combination of GluR1-GluR4 subunits (Hollmann and Heinemann, 1994; PellegriniGiampietro et al., 1997) . Most of the AMPA receptors are highly permeable to Na + and K + , and mediate rapidly, evolving and desensitizing components of excitatory postsynaptic currents. In contrast to NMDA, a prolonged (>60 min) activation of AMPA receptors is required to trigger neuronal death (Koh et al., 1990) . While most neurons express the GluR2 subunit that renders AMPA receptors impermeable to Ca 2+ , the expression and function of GluR2 appear to be reduced in neurons that are vulnerable to hypoxic-ischemic insults. A transient forebrain ischemia produces delayed neuronal death in the CA1 hippocampal area that is preceded by the down-regulation of the GluR2 mRNA expression (Pellegrini-Giampietro et al., 1992; Gorter et al., 1997) . NADPH diaphorase-containing neurons in the cortex and striatum express Ca 2+ -permeable AMPA receptors, and can undergo degeneration following a brief (~10 min) exposure to AMPA (Weiss et al., 1994) . A single-cell RT-PCR analysis demonstrated that striatal diaphorase-containing neurons reveal a reduced ratio of GluR2/GluR1 and an unedited expression of GluR2 mRNA . This altered expression of GluR2 results in Ca
-dependent AMPA neurotoxicity that may underlie potential mechanisms for selective neuronal death following hypoxic-ischemic brain injury.
The GluR5-7 and KA1-2 proteins comprise the subunits for functional KA receptors that are permeable to Na + and K + . The administration of kainate produces non-desensitizing currents at the AMPA receptors and fast desensitizing currents at the kainate receptors. Like the AMPA-mediated slow excitotoxicity, a prolonged (>1 h) exposure to kainate is needed to trigger neuronal death. It has been well-documented that the Ca 2+ entry through the NMDA or AMPA receptors mediates the fast excitotoxicity; however, it still needs to be delineated to see how slowly excitotoxicity is triggered and propagated. One possibility is that the Na + entry through the AMPA or kainate receptors likely contributes to the AMPAor kainate-mediated slow excitotoxicity.
Ca
2+ overload-induced neuronal death following hypoxicischemia The concentration of free Ca 2+ in the cytoplasm of a resting neuron is extremely low (approximately 100 nM), whereas its extracellular concentration is estimated to 1-2 mM. The intraneuronal levels of Ca 2+ are maintained through the following: (1) -ATPase, or mitochondria through electrophoretic (uniport) mechanisms (Gill et al., 1989; Gunter and Pfeiffer, 1990; Carafoli, 1991) . Thus, energy failure in hypoxicischemia will cause the accumulation of intraneuronal free Ca 2+ (Ca 2+ overload) by enhancing the entry and release of Ca
2+
, and interfering with the ATP-dependent extrusion and sequestration of Ca
. The entry of Ca 2+ through NMDA receptors appears to underlie a major portion of the Ca 2+ overload following hypoxic-ischemia, as NMDA antagonists block the entry and accumulation of Ca 2+ in central neurons that are deprived of oxygen and glucose (a hypoxic-ischemic condition in vitro) (Goldberg et al., 1987; Greenberg et al., 1990) . Prolonged elevation of intracellular Ca 2+ leads to the catabolic process of vital molecules and the irreversible death of neuronal cells through multiple mechanisms that involve the activation of Ca -dependent cysteine proteases that consist of a 80 kD catalytic subunit and a 30 kD subunit (Sorimachi et al., 1997) . Active calpain cleaves the vital proteins, such as spectrin, fodrin, Ca 2+ -ATPase, and protein kinase C, nuclear factor kappa B (Liu et al., 1996; Carafoli and Molinari, 1998) . This contributes to the dendritic remodeling, interruption of membrane and cytoplasmic transportation, modulation of gene expression, and neuronal degeneration (Wang et al., 1990; Faddis et al., 1997; Wang, 2000) . The activation of calpain I has been reported, following the activation of ionotropic glutamate receptors or hypoxic-ischemic insults (Seubert et al., 1988; Ostwald et al., 1993; Roberts-Lewis et al., 1994) . Selective inhibitors of calpain I can reduce the NMDA-, kainate-, or AMPA-mediated excitotoxicity to some extent, and attenuate brain damage after hypoxia, focal cerebral ischemia, or transient global cerebral ischemia (Lee et al., 1991; Rami and Krieglstein, 1993; Hong et al., 1994) . However, causative activation of calpain I for excitotoxicity has been challenged with findings that suggest that the blockade of calpain I by several inhibitors does not protect neurons from glutamate neurotoxicity (Manev et al., 1991; Faddis et al., 1997) . In addition to calpains, other proteases, such as cathepsin D, are activated in cortical neurons that are exposed to NMDA or kainate (Yoon and Gwag, unpublished data). They are, therefore, likely to be involved in the process of excitotoxicity. -activated cPLA2 produces free fatty acid (e.g. arachidonic acid) and lysophospholipids by catalyzing the cleavage of the free fatty acid from glycerophospholipids. Arachidonic acid is further utilized for the production of prostaglandins and leukotrienes with a concomitant production of superoxide (Kramer and Sharp, 1997; Sapirstein and Bonventre, 2000) . The activation of cPLA2 may contribute to neuronal death in excitotoxicity and hypoxic-ischemia. The activity of cPLA2 is increased following focal cerebral ischemia, or in cultured neurons following the activation of ionotropic glutamate receptors (Dumuis et al., 1990; Lazarewicz et al., 1990; Sanfeliu et al., 1990; Kim et al., 1995; Saluja et al., 1997) . Pharmacological inhibitors of cPLA2 reduce excitotoxic and hypoxic-ischemic neuronal death (Rothman et al., 1993; Bonventre, 1997) . Moreover, knockout mice of cPLA2 (cPLA2-/-) substantially reduce cerebral infarct, brain edema, and neurological deficits following occlusion of the middle cerebral artery . Direct application of cPLA2 or melittin, a cPLA2 activator, produces neuronal death in cultured neurons and rats (Clapp et al., 1995) . Thus, the Ca 2+ overload through glutamate receptors induces the activation of cPLA2 that produces neurotoxic metabolites, such as prostaglandins, leukotrienes, reactive oxygen species, and platelet activating factors through the metabolism of arachidonic acid and lysophospholipids. While cPLA2 partly mediates the Ca 2+ -dependent excitotoxicity and hypoxic-ischemic injury, further study will be needed in order to delineate how the neurotoxic metabolites are coupled to the propagation and execution of neuronal death after hypoxic-ischemic injury. -dependent inhibition, or the activation of the calcium/calmodulin protein kinase II (CaMK II) in the cortical and hippocampal neurons through the activation of NMDA glutamate receptors (Fukunaga et al., 1992; Morioka et al., 1995; Churn et al., 1995) . The activity of CaMK II is decreased in a way that is sensitive to NMDA antagonists that rapidly follow transient focal or global cerebral ischemia (Hanson et al., 1994; Shackelford et al., 1995) . While homozygous knock-out mice that lack the alpha subunit of CaMK II enhances sensitivity to hypoxic-ischemic insults in vivo (Waxham et al., 1996) , a selective cellpermeable inhibitor of CaMK II (KN62) attenuates neuronal death, following exposure to NMDA, or the deprivation of oxygen-glucose in vitro (Hajimohammadreza et al., 1995) . Therefore, the exact role of CaMK II needs to be studied in order to increase our understanding and assist in the therapeutic prevention of excitotoxic and hypoxic-ischemic neuronal death.
The administration of excitotoxins can activate major members of the mitogen-activated protein kinase (MAPK) family: p42/p44 extracellular signal-regulated kinases (ERK1 and 2), c-Jun N-terminal protein kinase (JNK)/stress-activated protein kinases (SAPKs), and p38 (Xia et al., 1996; Kawasaki et al., 1997; Ko et al., 1998; Vanhoutte et al., 1999; Schwarzschild et al., 1999) . SAPK and p38 act as downstream mediators for the execution of neuronal and nonneuronal cell apoptosis (Cross et al., 2000) . While activated p38 MAPK appears to mediate the NMDA-induced neuronal apoptosis in cerebellar granule cells (Kawasaki et al., 1997) , inhibitors of p38 did not reduce the NMDA-induced neuronal cell necrosis in cortical cell cultures (Ko et al., 2000) . In a recent report, PD98059 (a selective ERK inhibitor) was shown to reduce the infarct volume up to 55% by 1 d, and 36% by 3 d following occlusion of the middle cerebral artery (Alessandrini et al., 1999) . In addition to p38, ERKs and SAPKs probably participate in the process of excitotoxicity, as well as hypoxic-ischemic neuronal death. (Robertson et al., 2000) . The administration of glutamate, NMDA, AMPA, or kainate produces DNA ladders in cultured neurons and rat brains (Ankarcrona et al., 1995; Portera-Cailliau et al., 1995; Gwag et al., 1997) . Although the activation of caspase-3 mediates the liberation of caspaseactivated DNase (CAD)/DNA-dependent protein kinase-40 (DFF-40) by cleaving to the inhibitor of CAD (ICAD)/DFF-45 then producing DNA ladders, the excitotoxins appear to produce DNA ladders through the activation of CADindependent endonucleases, since excitotoxins-induced DNA ladders are produced in the absence of caspase-3 activation (Gwag et al., 1997; Ko et al., 2000) . The process of DNA fragmentation has been implicated in chromatin condensation and morphological changes of nucleus in non-neuronal cells (Woo et al., 1998; Enari et al., 1998) , but its role in excitotoxic neuronal death needs to be resolved. (e) Nuclear factor kappa B The transcription factor, nuclear factor kappa B (NF-κB), plays a dynamic role in the survival and death of neuronal and non-neuronal cells under physiological and pathological conditions (Baeuerle and Baltimore, 1996) . Much research has established that the activation of NF-κB enhances neuronal survival by preventing apoptosis. The activation of NF-κB by cytokines appears to be required for preventing the apoptosis of sensory neurons, which is documented by findings that the anti-apoptosis action of cytokines disappears in neurons that are treated with a super-repressor IkappaB-alpha protein, or lacking the RelA (p65) subunit of NF-κB (Middleton et al., 2000) . The inhibition of NF-κB renders various types of cells highly vulnerable to apoptosis (Taglialatela et al., 1997) . In contrast to the anti-apoptosis action of NF-κB, controversial results have appeared regarding the causative role of NF-κB to excitotoxicity. Treatment with TNF or C2-ceramide reduced the excitotoxicity and free radical neurotoxicity through mechanisms that involved the activation of NF-κB (Goodman and Mattson, 1996; Mattson et al., 1997) . The administration of excitotoxins induces the activation of NF-κB in neurons in vitro and in vivo (Grilli et al., 1996; Won et al., 1999) . A causative activation of NF-κB has been proposed from findings that aspirin or salicylate prevents NMDA neurotoxicity by blocking the activation of NF-κB (Grilli et al., 1996) . However, this possibility has been challenged with the inhibitory action of aspirin or salicylate against the NMDA-induced activation of SAPK (Ko et al., 1998) . Therefore, the exact role of NF-κB in excitotoxicity needs to be reexamined, turning to the pharmacological and genetargeted knockout of NF-κB. (f) Mitochondria Mitochondria constitute approximately 25% of the cytoplasmic volume, and produce cellular energy in the form of ATP via the electron transport and oxidative phosphorylation in most eukaryotic cells. Mitochondria are recognized as target organelles for the regulation and execution of cell death under pathological conditions (Budd and Nicholls, 1998; Kroemer et al., 1998) . The role of mitochondria in excitotoxicity stems from various observations. First, the entry and accumulation of cytoplasmic Ca 2+ through ionotropic glutamate receptors results in the subsequent accumulation of Ca 2+ in mitochondria ([Ca 2+ ] m ) (White and Reynolds, 1997; Peng et al., 1998) . The cytoplasmic Ca 2+ is transported into mitochondria through an electrophoretic uniporter. Its driving force is generated by the negative membrane potential, ∆ψ m (Gunter and Gunter, 1994) . Second, mitochondria become depolarized, due to the transport of Ca 2+ into the matrix and the inhibition of the oxidative phosphorylation (White and Reynolds, 1996; Ward et al., 2000; Rego et al., 2000) . Third, inhibiting the mitochondrial Ca 2+ uptake reduces the Ca 2+ -mediated glutamate neurotoxicity (Stout et al., 1998) . Finally, increasing the mitochondrial membrane and redox potential blocks the accumulation in [Ca 2+ ] i and neuronal death following the activation of NMDA receptors (Seo et al., 1999) . Excess Ca 2+ in mitochondria results in mitochondrial dysfunction and neuronal death in various ways. With the accumulation of [Ca 2+ ] m , ATP synthesis in mitochondria is impaired, due to the collapse of the mitochondrial oxidative phosphorylation Khodorov et al., 1996) . ATP depletion will interfere with the actions of ATPdependent Ca 2+ pumps, amplify the accumulation of [Ca 2+ ] i , therefore enhancing the process of excitotoxic neuronal death. The activation of NMDA receptors produces reactive oxygen species in mitochondria, primarily through the inhibition of the oxidative phosphorylation and membrane potential Seo et al., 1999) . Ca 2+ -induced mitochondrial damage causes increased mitochondrial membrane permeability (Dubinsky and Levi, 1998) , which can result in the mitochondrial release of cytotoxic substances, such as cytochrome c (Luetjens et al., 2000) .
Oncosis versus apoptosis
The activation of ionotropic glutamate receptors allows the entry of Ca 2+ and Na + through the plasma membrane. The massive entry and accumulation of the cations induce the secondary influx of Cl -and H 2 O, resulting in a marked swelling of the neuronal cell body within a few hours (Choi, 1987) . Transmission electron microscopy reveals the swelling of cytoplasmic organelles, including mitochondria and the scattering condensation of nuclear chromatin early in the process of excitotoxicity (Gwag et al., 1997) . Plasma membrane and cytoplasmic organelles are disrupted, but the nuclear membrane remains intact. In contrast to apoptosis (shrinkage necrosis), membrane blebbing is not observed in the process of excitotoxicity. The morphological features suggest that neurons undergo 1 oncosis (swelling necrosis) following the superfluous activation of NMDA, AMPA, or kainate receptors. Although DNA ladders, TUNEL-positive neurons, and chromatin condensation are visible by DNA-binding, fluorescence dyes have been used as evidence of apoptosis in excitotoxicity (Ankarcrona et al., 1995; Portera-Cailliau et al., 1995) ; they are all observed in the process of necrotic cell death or oncosis Charriaut-Marlangue and Ben-Ari, 1995; Grasl-Kraupp et al., 1995; Sohn et al., 1998) . Excitotoxic neuronal oncosis appears to propagate through signal transduction, which is different than oxidative stress and apoptosis, as neither antioxidants nor anti-apoptosis agents (e.g. inhibitors of macromolecule synthesis or growth factors) prevent excitotoxicity (Gwag et al., 1997 and .
Limitation of anti-excitotoxicity therapy for hypoxicischemic injury
The blockade of excitotoxicity can be applied to treat fulminant neuronal death that appears in hypoxic-ischemic patients. Therefore, a number of NMDA and AMPA/kainate receptor antagonists were developed for the prevention of hypoxic-ischemic neuronal death. Several NMDA receptor antagonists, including MK-801 and dextrophan, provide substantial protection against ischemic injuries that are induced by oxygen-glucose deprivation in vitro, or occlusion of the middle cerebral artery (Simon et al., 1984; Goldberg et al., 1987) . Although NMDA receptor antagonists should be promptly delivered to ischemic patients for appropriate efficacy, most patients are hospitalized after 3 h after the onset of symptoms. The therapeutic potential of NMDA receptor antagonists is further limited by behavioral effects, such as psychosis and hyperlocomotion (Ouagazzal et al., 1993; Ellison, 1995) , which are less protective effects against global ischemic injuries (Ross and Duhaime, 1989; , and direct neurotoxicity in several areas of the brain (Olney et al., 1991) . While antagonists (such as NBQX) that act on AMPA and kainate receptors mitigate a selective neuronal loss following transient global ischemia in the rat (Sheardown et al., 1990) , they are partially neuroprotective against focal ischemic insults . The co-administration of NMDA and AMPA/kainate antagonists blocks excitotoxic neuronal oncosis, but reveals slowly-evolving apoptosis following hypoxic-ischemic insults . Therefore, applying glutamate antagonists in order to treat hypoxic-ischemic injury should be compromised with the deleterious effects of the antagonist itself and appearance of glutamate-independent death pathways (e.g. apoptosis and oxidative stress). The former can be avoided with channel-blocking NMDA receptor antagonists with low affinity and a rapid-kinetic response (Rogawski et al., 2000) .
Oxidative stress
Free radicals play an essential role in maintaining the physiological condition of the body. But, oxidative stress that is induced by an excess accumulation of the reactive oxygen species can damage basic components for cell function and survival. The brain accounts for about 20% of the aerobic metabolism. Neuronal cells are exposed to a minimum level of free radicals from both exogenous and endogenous sources in the normal condition. Since the brain has a minimum storage capacity for oxygen and a high probability of lipid peroxidation, then brain cells are especially vulnerable to free radical-mediated injury, such as oxygen interruption and reperfusion (Fig. 2) .
Production of reactive oxygen species by Ca
2+
The loss of ATP during hypoxic-ischemia induces the dysfunction of active ion pumps, such as Na + , K + -ATPase (Welch et al., 1997 ). An abnormality of transmembrane ion gradient leads to neuronal plasma membrane depolarization, which opens the voltage-gated Ca 2+ and Na + channels. The depolarization also stimulates the release of neurotransmitters, including glutamate into the synaptic cleft (Nicholls and Attwell, 1990) . The accumulation of Ca 2+ in neurons by the activation of Ca 2+ -permeable glutamate receptors produces free radicals through the activation of prooxidant pathways, including phospholipases (Sevanian et al., 1983; Au et al., 1985) , xanthine oxidase (McCord et al., 1985) , and nitric oxide synthase (Dawson et al., 1992) . The administration of glutamate to central neurons activates xanthine oxidase through the activation of NMDA receptors and Ca 2+ -dependent proteases (Atlante et al., 2000) . Accumulated [Ca 2+ ] i induces the activation of the neutral protease calpain that results in the conversion of xanthine dehydrogenase into xanthine oxidase. Xanthine oxidase catalyzes the oxidation of xanthine and hypoxanthine into uric acid, producing superoxide as a by-product (McCord et al., 1985) .
Production of reactive oxygen species in mitochondria
Mitochondria produce ATP by utilizing about 90% of O 2 that is taken up by neurons. During the electron transfer in the inner mitochondrial membrane, electrons spontaneously leak from the electron transport chain and react with available O 2 to produce superoxide. The superoxide is normally cleared to H 2 O by superoxide dismutases and glutathione peroxidase. But, many free radicals that cannot be cleared by antioxidant enzymes are generated during ischemia, especially in reperfusion (Cao et al., 1988 ). An increase of oxygen during reperfusion induces the uncoupling of the electron flow from the mitochondria electron transport chain, causing the accumulation of free radicals. During hypoxic-ischemic injury, Ca 2+ is accumulated in the cytosol (see above) and enters into mitochondria, which results in the production of mitochondrial free radicals (Hasegawa et al., 1993; Dykens, 1994; Dugan et al, 1995; Giulivi et al., 1995; Piantodosi and Zhang, 1996) . Excess Ca 2+ in the mitochondria interrupts the electron transport chain and collapses the mitochondrial membrane potential (Zhang et al., 1990; Rego et al., 2000) . Therefore, free electrons are accumulated in the mitochondria, which react with oxygen that is supplied after reperfusion, and causes the production of superoxide. The superoxide is further processed to produce the hydroxyl radical by a Fenton reaction or peroxynitrite by reacting with nitric oxide. The reactive oxygen and nitrogen species (ROS and RNS) also inhibit the electron transport chain in the mitochondria, and amplify a generation of mitochondrial free radicals (Zhang et al., 1990; Radi et al., 1994; Schweizer and Richter, 1994; Takehara et al., 1995; Cassina and Radi, 1996) . Therefore, mitochondrial oxidative damage involves mitochondrial lipid peroxidation (Radi et al., 1993) and mitochondrial DNA oxidation (Giulivi et al., 1995) . Piantodosi and Zhang (1996) reported that the microdialysis of the hippocampus of rats that underwent transient global ischemia and reperfusion indicated a significant free radical formation during reperfusion. This ROS generation was also inhibited by infusion through the microdialysis probe of the complex I inhibitor, rotenone. Hasegawa (1993) , and other studies using non-neuronal cells, provided evidence that mitochondria are free radical sources during ischemia. The reaction between superoxide and NO was reported to mediate toxicity that is associated with ischemia and reperfusion (Dawson et al., 1992; McCord et al., 1985) .
Reactive nitrogen radicals Nitric oxide (NO or nitrogen monoxide) is an important messenger molecule in physiological conditions, and is synthesized by the activation of nitric oxide synthase (NOS). Ca 2+ /calmodulin-dependent NOSs, such as neuronal NOS (nNOS) and endothelial NOS (eNOS), are activated by raised [Ca 2+ ] i (Knowles and Moncada, 1994) . The expression of inducible NOS (iNOS) is increased in astrocytes and microglia by various cytokines, including interleukin-1, interleukin-2, interferon-γ, or the tumor necrosis factor (Murphy et al., 1993; Merrill et al., 1997) . NO may exert neurotoxicity or neuroprotection, depending on the isoforms and localization of the activated NOS (Shim et al., 2001) .
nNOS is expressed primarily in NADPH-diaphorasecontaining neurons, and activated by raised Ca 2+ during hypoxic-ischemic injury (Lipton et al., 1993; Samdani et al., 1997) . Inhibiting nNOS reduced the NMDA-mediated excitotoxicity, focal cerebral ischemia, global ischemia, and common carotid artery thrombosis (Dawson et al., 1993; Yoshida et al., 1994; ONeil et al., 1996; Kahn et al., 1997; Matsui et al., 1997; Stagliano et al., 1997; Nanri et al., 1998) . NO that is derived from neurons can diffuse freely across membranes, and cause a degeneration of surrounding neurons. NO may react with superoxide to produce peroxynitrite (ONOO − ), another highly reactive free radical, that appears to mediate toxicity that is associated with ischemia and reperfusion (Radi et al., 1991a, b; Radi et al., 1994; Kooy et al., 1994) . Peroxynitrite is ultimately converted to hydroxyl radical and nitrogen dioxide. These free radicals cause tissue damage by the nitration of DNA and proteins, as well as the oxidization of lipids, DNA, and proteins (Beckman, 1996; Yermilov et al., 1996) . In addition, NO may produce neuronal death by activating poly (ADP-ribose) synthetase, thereby depleting beta-nicotinamide adenine dinucleotide (Zhang et al., 1994) , and inhibiting mitochondrial ATP synthesis as an electron acceptor (Brookes et al., 1999) .
NO can be produced in the endothelial cells of blood vessels through the activation of eNOS, released, and influence hypoxic-ischemic brain injury. Endothelial NO mediates vasodilation and prevents thrombosis. Therefore, endothelial NO appears to act as a neuroprotective signal against hypoxic-ischemia. This has been supported by recent findings that show that the inhibition of eNOS worsens neuronal death after hypoxic-ischemia (Dalkara et al., 1994; Shapira et al., 1994; Stagliano et al., 1997) . Finally, the expression of iNOS increased in glial cells and neutrophils several days after reperfusion, which provided a substantial amount of NO in the ischemic area (Iadecola et al., 1995a) . The induction of iNOS potentiates neuronal death following the deprivation of oxygen and glucose, while the inhibition of iNOS reduces the infarct volume after transient cerebral ischemia (Iadecola et al., 1995b) . Increased levels and activation of iNOS appear to contribute to a somewhat delayed neurotoxicity following hypoxic-ischemic injury.
Production of reactive oxygen species by transition metals
Transition metals are one of the most important factors that produce the reactive oxygen species, and they are implicated in the generation of ROS in various neurodegenerative diseases (Youdim et al., 1993; Deibel et al., 1996) . These transition metals mediate the formation of the hydroxyl radical through the iron-catalyzed or copper-catalyzed HaberWeiss reactions (Haber and Weiss, 1934) . Fe 2+ is released from surrounding cells and iron-binding proteins during transient focal ischemia. The released Fe 2+ can also convert hydrogen peroxide to hydroxyl radical, and may mediate lipid peroxidation during reperfusion (White et al., 1985; Zaleska and Floyd, 1985) . Late-onset iron deposition was also observed after transient focal ischemia in rat brain (Kondo et al., 1995) . The transition metal Zn 2+ mediates the death of neuronal and non-neuronal cells in hypoxic-ischemia, epilepsy, and trauma (Koh et al., 1996; Cole et al., 2000; Lee et al., 2000; Suh et al., 2000) . Zn 2+ is stored in the presynaptic vesicles of glutamatergic neurons, released with glutamate in an activity dependent manner, and translocated into adjacent neurons (Frederickson and Moncrieff, 1994) . The Zn 2+ translocation was observed in degenerating neurons after transient forebrain ischemia (Koh et al., 1996; Suh et al., 2000) . (Freund and Reddig, 1994; Koh and Choi, 1994; Sensi et al., 1997; Sensi et al., 1999; Colvin et al., 2000) . The entry and accumulation of Zn 2+ into neurons result in the transient generation of reactive oxygen species that mediate latent neuronal death . Zn 2+ produces ROS, possibly through the activation of cyclooxygenases and PKC Noh and Koh, 2000) . Also, Zn 2+ induced neuronal cell death by energy failure and the addition of pyruvate attenuated cell death, recovered the level of ATP and NAD (+) (Sheline et al., 2000) . In addition, pyruvate prevented neuronal death following transient forebrain global ischemia .
Metabolism of arachidonic acid
Glutamate or hypoxicischemia produces arachidonic acid through the activation of PLA 2 (see above). Arachidonic acid is converted into eicosanoids with a concomitant production of superoxide by cyclooxygenases and 5-lipooxygenase (Kontos, 1987; Krause et al., 1988 ). An increased expression and activation of COX-2 was observed in neurons and glial cells in rodent and human ischemic brains (Planas et al., 1995; Collaco-Moraes et al., 1996; Sairanen et al., 1998) . They were shown to depend upon activation of NMDA receptors in neurons (Miettinen et al., 1997) . COX-2 inhibition attenuates NMDA-mediated excitotoxicity and hypoxic-ischemic injury (Hewett et al., 2000; Iadecola et al., 2001) . Recently, the activation of constitutive COX-2 was shown to mediate Zn 2+ -induced free radical production and neurotoxicity in cortical cell cultures . The exact role of activated COX-2 in neurons and non-neuronal cells needs to be determined in order to correlate the free radical production and neuronal death following hypoxic-ischemia. However, hypoxicischemic injury worsened with the reduction of cerebral blood flow at the periphery of the ischemic territories in COX-1 deficient mice (Iadecola et al., 2001) . The inhibition of lipoxygenase, the other catalytic enzyme of arachidonic acid, attenuates neuronal injury that is induced by oxygen-glucose deprivation in a hippocampal slice (Arai et al., 2001) .
Apoptosis versus oncosis Accumulated ROS in cells are expected to randomly attack DNA, lipid, and proteins; therefore, they produce cell death in a way that is different than apoptosis, which is propagated through a cascade of well-orchestrated molecular events. However, a lot of evidence suggests that ROS may act as mediators of apoptosis in non-neuronal cells. First, ROS are produced in the process of apoptotic cell death (Hockenbery et al., 1993; Bredesen, 1994; Prehn et al., 1997; Krohn et al., 1998) . Second, ROS scavengers prevent apoptosis (Hockenbery et al., 1993; Troy and Shelanski, 1994; Greenlund et al., 1995; Kruman et al., 1998) . Third, exposure to pro-oxidants can induce apoptosis (Ratan et al., 1994; Whittemore et al., 1995) . The causative role of ROS for apoptosis has been reported in various populations of neurons (Ratan et al., 1994; Whittemore et al., 1995) . These turn mainly to DNA ladders, DNA-binding fluorescence dyes, and the TUNEL method that do not differentiate apoptosis from oncosis (see above). We also observed that cortical cell cultures are exposed to prooxidants, such as Fe 2+ or buthionine sulfoximine revealed DNA ladders, condensation of nuclear chromatin, and TUNEL-positive neurons (Ryu et al., 1998) . However, an ultrastructural analysis of free radical neurotoxicity demonstrated the occurrence of typical oncosis in most neurons, which is evident by the swelling of the cell body and mitochondria, scattering condensation of nuclear chromatin, and fenestration of the plasma membrane prior to nuclear membrane (Ryu et al., 1998) .
Limitation of anti-oxidant therapy for hypoxic-ischemic injury As documented, free radicals (e.g. ROS and RNS) contribute to hypoxic-ischemic neuronal death. The pharmacological or genetic intervention of ROS and RNS has been neuroprotective against hypoxic-ischemic injury, as discussed previously. However, neither tirilazad mesylate (a lipid peroxidation inhibitor), nor ebselen (a seleno-organic compound with antioxidant activity) failed to show therapeutic efficacy in the primary outcome measure of stroke patients. This lack of efficacy may be attributed to the inappropriate administration of drugs, which were insufficient to block the ROS production following hypoxic-ischemia. In addition, the blockade of ROS neurotoxicity may result in the appearance of the other death pathways, excitotoxicity, and apoptosis. Kerr et al. (1972) reported electron microscopic features of shrinkage necrosis or apoptosis that could play a role in the regulation of cell numbers under physiological and pathological conditions. The condensation of nucleus and cytoplasm, nuclear fragmentation, and the aggregated Fig. 3 . Multiple pathways for hypoxic-ischemic neuronal apoptosis. condensation of nuclear chromatin accompanied apoptotic cells. Interestingly, apoptosis is prevented by the inhibitors of protein and mRNA synthesis; therefore, they appear to require the expression and activation of death-regulating proteins in neurons and non-neuronal cells (Wyllie et al., 1984; Martin et al., 1988) . The morphological and molecular features of apoptosis have been reported in the nervous system during development and various neurological diseases. Apoptosis has been recognized as an additional pattern of hypoxic-ischemic neuronal death. Various pro-apoptosis proteins are activated in ischemic brain areas, and inhibitors of protein synthesis attenuate hypoxic-ischemic neuronal death (Fig. 3) . The inhibitors of caspases, or the overexpression of Bcl-2, attenuate neuronal death following focal and global ischemia. Although evidence has accumulated that demonstrates the occurrence of neuronal apoptosis after hypoxic-ischemic insults, there remains the need to determine how the interruption of the blood supply to the brain triggers neuronal cell apoptosis.
Apoptosis
Acidosis
The decrease of blood flow (<50%) by hypoxicischemic injury induces the depletion of ATP and the accumulation of lactate within a few minutes (Welch et al., 1997) . The intracellular acidification by excess CO 2 , and the dysfunction of active ion pumps by the loss of ATP, is considered a primary cause of cell death (Siesjo et al., 1996) . The possibility has been raised that the intracellular acidification comprises an event in the process of apoptosis, such as an increase of ICE-like protease activity (Furlong et al., 1997; Matsuyama et al., 2000) . The collapse of the proton gradient across the mitochondrial inner membrane by a decrease of ATP can result in a complete loss of the mitochondrial membrane potential. The cytochrome c in the cytosol that is released by the permeability of the outer mitochondrial membrane binds to Apaf-1, activates procaspase-9, and leads to the activation of downstream caspases, such as caspase-3 (Earnshaw et al., 1999) . Hypoxicischemia, or the apoptosis-inducing protein kinase inhibitor staurosporine, causes acidification in the cytosol that promotes the activation of cytochrome c-dependent caspases and acidic endonucleases (Matsuyama et al., 2000) . The intracellular acidification caused apoptosis in cultured neurons and haematopoietic cells (Furlong et al., 1997; Ding et al., 2000) . Growth factors, and the anti-apoptosis members of Bcl-2, prevented cytosolic acidification, which probably resulted in the attenuation of caspase activation and apoptosis Furlong et al., 1997; Khaled et al., 1999) . It is possible that acidosis may mediate neuronal apoptosis following hypoxic-ischemic insults.
Calcium imbalance Hypoxic-ischemic insults to the brain can cause an excess accumulation of Ca 2+ in neurons (see above). While the disrupted ion homeostasis produces neuronal cell oncosis (as shown in excitotoxicity), the selective accumulation of intracellular Ca 2+ can cause neuronal apoptosis. Raised [Ca 2+ ] i by Ca 2+ ionophores causes neurite damage, depriving cell bodies of target-derived neurotrophic factors. It then produces hallmarks of apoptosis, such as DNA ladders, shriveled cell body, aggregated and condensed nuclear chromatin, and sensitivity to various anti-apoptosis agents . When neurons are exposed to NMDA in low levels of extracellular Na + , they become more permeable to Ca 2+ , and reveal apoptotic features (Yu et al., 1999) . Raised [Ca 2+ ] i can trigger apoptosis through mechanisms that involve the activation of calpain, caspases, PLA 2 , and endonucleases, which is observed following the focal and global cerebral ischemia (Rordorf et al., 1991; Neumar et al., 1996; Rosenbaum et al., 1998; Namura et al., 1998) .
Fas receptor
The death receptor Fas (CD95 or APO-1) belongs to the tumor necrosis factor (TNF) receptor superfamily, and plays a role in death and survival, as well as proliferation and differentiation (Nagata, 1997; Strasser et al., 2000) . Fas ligand (Fas-L) activates Fas in an autocrine or paracrine fashion, which causes the trimerization of Fas with Fas-associating proteins with death domain (FADD) and procaspase-8. The activation of Fas has been demonstrated as a necessary step for apoptosis of neuronal cells that are deprived of trophic factors (Cheema et al., 1999; LeNiculescu et al., 1999; Raoul et al., 1999) . The expression of Fas and Fas-L is increased in the ischemic brain area following hypoxic-ischemic injury (Matsuyama et al., 1995; Herdegen et al., 1998; Martin-Villalba et al., 1999; Felderhoff-Mueser et al., 2000; Matsushita et al., 2000) . The recruitment of FADD, and procaspase-8 or 10, to Fas is observed in the cerebral cortex and hippocampal formation that is subjected to focal cerebral ischemia and global forebrain ischemia, respectively (Won et al., 2000; Jin et al., 2001) . This implies that the Fas-mediated death pathway may underlie hypoxic-ischemic neuronal apoptosis. In support of this, the infarct size following occlusion of the middle cerebral artery is reduced in lpr mice that are deficient in Fas (MartinVillalba et al., 1999) . Further study will be needed to understand the mechanisms for the expression of Fas and Fas-L, and to correlate the Fas pathway and neuronal apoptosis following hypoxic-ischemic injury.
MAP kinases MAPKs, p42/p44 extracellular signalregulated kinases (ERK 1 and 2), c-Jun N-terminal kinases (JNK), and p38 mitogen-activated protein kinase, play a role in the development and survival of neurons and non-neuronal cells (Ip and Davis, 1998) . Among these, JNK and p38 have been established as the common mediators of cell death (Mielke and Herdegen, 2000) . In the brain, JNK and p38 are activated to execute apoptotic death of neuronal cells following trophic factor deprivation, or exposure to calyculin A, Haloperidol or NO donors (Xia et al., 1995; Kummer et al., 1997; Ko et al., 1998; Maroney et al., 1998; Ghatan et al., 2000) . The activation of JNK and p38 is also observed in the vulnerable brain areas after hypoxicischemic injury (Herdegen et al., 1998; Ozawa et al., 1999; Irving et al., 2000) . The administration of SB203580, a p38 inhibitor, reduces the infarct size after the transient focal cerebral ischemia, and the delayed neuronal death in the CA1 sector after global forebrain ischemia (Sugino et al., 2000; Barone et al., 2001) . This suggests that p38, and possibly JNK, may mediate the execution of hypoxic-ischemic neuronal apoptosis. Activated JNK and p38 may execute apoptosis by preventing the anti-apoptosis actions of Bcl-2 and Bcl-X L . This activates the translocation of the cytosolic Bax into mitochondria, which then activates the mitochondrial apoptosis signals, such as the cytochrome c release (Srivastava et al., 1999; Kharbanda et al., 2000; Ghatan et al., 2000; Tournier et al., 2000) . In recent U0126, a specific inhibitor of MEK (MAPK/ERK kinase), protected the hippocampal neuronal death after the forebrain ischemia concurrent with a reduction of ERK2 phosphorylation (Namura et al., 2001) .
The pro-apoptotic family of Bcl-2 The physiological and pathological roles of the Bcl-2 family of proteins have been extensively reviewed (Merry and Korsmeyer, 1997; Chao and Korsmeyer, 1998) . In general, the physical balance between anti-apoptotic and pro-apoptotic members of the Bcl-2 family appears to determine the death and survival of developing and mature cells. The pro-apoptotic Bcl-2 family includes Bax, Bcl-x s , Bak, Bad, and Bid. They participate in the process of hypoxic-ischemic neuronal death. The expression of Bax is increased selectively in neurons undergoing apoptosis after global forebrain ischemia and focal cerebral ischemia (Krajewski et al., 1995; Isenmann et al., 1998) . The cerebral infarct, and the delayed neuronal death in the hippocampus, are significantly reduced in mice and gerbil that over-express Bcl-2, respectively (Martinou et al., 1994; Snider et al., 1999; Antonawich et al., 1999) . Hypoxic-ischemia can activate the pro-apoptotic Bcl-2 family, possibly through two separate routes. The intracellular acidosis can induce a pH-sensitive conformational change of Bax, then the translocation of Bax into mitochondria (Khaled et al., 1999) . Bax is oligomerized, inserted into the outer membrane of mitochondria, and in turn shown to induce the cytochrome c release, caspase activation, and apoptosis (Hsu et al., 1997; Gross et al., 1998) . Alternatively, raised [Ca 2+ ] i induces the BAD dephosphorylation and dissociation from 14-3-3 in the cytosol through the activation of the protein phosphatase calcineurin, which results in the BAD translocation to mitochondria and heterodimerization with Bcl-xL (Wang et al., 1999; Khaled and Durum, 2001) ). Bid, another pro-apoptotic Bcl-2 family, also mediates the caspase-8 dependent-neuronal death after oxygen-glucose deprivation, and focal cerebral ischemia. Also, Bid-/-mice are resistant to ischemic injuries against focal cerebral ischemia (Plesnila et al., 2001) .
Caspases The caspases, a family of cysteine-dependent aspartate-directed proteases, mediate the propagation and execution of apoptosis. They can be classified into "initiator caspases" and "effector caspases" (Earnshaw et al, 1999) . The initiator caspase, caspase-9, is proteolytically activated by apaf-1, a cytoplasmic protein that is homologous to ced-4, and cytochrome c. The mitochondria Bax-like proteins may rupture the outer mitochondrial membrane, or induce the formation of a channel complex for the cytochrome c release (Desagher and Martinou, 2000) . Another initiator caspase caspase-8 is activated through the interaction of procaspase-9 with the Fas receptor and FADD adapter. The activation of caspase-8, caspase-9, or caspase-10 is observed in the vulnerable brain areas prior to the appearance of neuronal apoptosis following global and focal hypoxic-ischemic injury in the brain Velier et al., 1999; Won et al., 2000; Jin et al., 2001) . Activated caspase-8 and caspase-9 can induce activation of downstream caspases, such as caspase-3, 6, and 7, that can cleave a number of proteins that are essential for the structure, signal transduction, and cell cycle. This results in the termination of the overall apoptosis process. Caspase-3-mediated neuronal death has been reported following hypoxic-ischemia in vitro and in vivo (Gottron et al., 1997; Chen et al., 1998; Namura et al., 1998; Fujimura et al., 1998; Sugawara et al., 1999) . Wyllie (1980) reported that genomic DNA cleaved into the oligonucleosomal size in the course of apoptosis. This internucleosomal DNA fragmentation (or DNA ladders) has been shown using the agarose gel electrophoresis of DNA and the terminal deoxynucleotidyl transferase mediated dUTPbiotin nick end labeling (TUNEL) method. It is widely accepted as a way to define apoptosis (Wyllie, 1980; Gavrieli et al., 1992) . In addition, the apoptotic condensation of the nuclear chromatin has been demonstrated using membranepermeable fluorochromes (e.g. Hoechst dye and propidium iodide) that bind to DNA (Nicoletti et al., 1991; Darzynkiewicz et al., 1992) . As DNA ladders, TUNELpositive neurons and chromatin condensation were observed in the process of neuronal death in the hypoxic-ischemic brain areas; apoptosis, as well as oncosis, have been considered as additional types of hypoxic-ischemic neuronal death (Linnik et al., 1993; MacManus et al., 1993; . However, similar patterns of DNA damage are observed in the process of the necrotic cell, suggesting that the analysis of DNA damage is insufficient to define apoptosis (Enlight et al., 1994; Grasl-Kraupp et al., 1995; Sohn et al., 1998) . The electron microscopic examination revealed that neurons primarily undergo oncosis that is evident by the swelling of the cell body and mitochondria, translucent cytoplasm, scattering condensation of the nuclear chromatin, and fenestration of the plasma membrane with the preserved nuclear membrane following occlusion of the middle cerebral artery (Fig. 4) . Similar morphological patterns of degenerating neurons were reported in the hippocampal region following global forebrain ischemia Colbourne et al., 1999) . Therefore, hypoxic-ischemic insults to the brain appear to produce neuronal cell oncosis, possibly through mechanisms that involve excitotoxicity and oxidative stress (Table 1) . While some biochemical and molecular events underlying apoptosis have been observed following focal cerebral ischemia and global forebrain ischemia, the fulminant necrotic pathway may override these. The apoptosis component of hypoxicischemic neuronal death may be revealed with the blockade of excitotoxicity and oxidative stress .
Reevaluation of ischemic neuronal apoptosis
Maximization for Prevention of Hypoxic-ischemic Neuronal Death
While antagonizing excitotoxicity does reduce neuronal death after hypoxic-ischemic injury, its beneficial effect is questioned by some unwanted observations. Systemic injections of NMDA antagonists alone produce neuronal vacuolization and death in adult rats (Fix et al., 1993) . Neuronal death by NMDA antagonists reveals a hallmark of apoptosis, such as shrinkage of the cell body, aggregated condensation of nuclear chromatin, and sensitivity to the inhibitors of protein synthesis (Fix et al., 1993; Ikonomidou et al., 1999; Hwang et al., 1999; Takadera et al., 1999) . In addition, a prolonged deprivation of oxygen and glucose undergoes slowly-evolving apoptosis through the activation of caspases under the blockade of excitotoxicity Gottron et al., 1997) . Accordingly, the combined treatment with a NMDA antagonist and a caspase inhibitor results in synergetic neuroprotection against hypoxic-ischemic injury in vitro and in vivo (Ma et al., 1998; Schulz et al., 1998; Allen et al., 1999; Choi, 2001) .
Neurotrophins enhance neuronal survival by preventing programmed cell death, or the apoptosis of developing neurons (Davies, 1994; Snider, 1994) . The neuroprotective effects of neurotrophins have been demonstrated under various pathological conditions. For example, neurotrophins protect various populations of neurons from axotomy (Hefti, 1986; Yan et al., 1992; Mey and Thanos, 1993; Chiu et al., 1994; Cohen et al., 1994; Mansour-Robaey et al., 1994; Friedman et al., 1995) . Neurotrophins can attenuate neuronal death following global or focal cerebral ischemia (Shigeno et al., 1991; Beck et al., 1994; Chan, 1996) . Besides their beneficial effects, neurotrophins appear to exacerbate neuronal injury under certain circumstances. BDNF, NT-3, or NT-4/5 renders neurons highly vulnerable to the deprivation of oxygen and glucose, possibly by enhancing the Ca 2+ influx through NMDA glutamate receptors, and thereby oncosis (Fernandez-Sanchez and Novelli, 1993; Koh et al., 1995) . BDNF or NGF potentiates neuronal cell oncosis by reactive oxygen species or nitric oxide (Gwag et al., 1996; Park et al., 1998; Ishikawa et al., 2000) . The neuroprotective action of neurotrophins therefore appears to be limited to apoptosis, and should be compromised with the potentiation effects of NMDA or free radical neurotoxicity.
Accumulating evidence demonstrates that excitotoxicity, oxidative stress, and apoptosis contribute to hypoxic-ischemic neuronal death through mutually exclusive pathways. To date, glutamate antagonists, anti-oxidants, or anti-apoptosis agents, such as growth factors, have been examined to treat hypoxicischemic brain injury. However, the therapeutic efficacy of neuroprotective drugs against each-excitotoxicity, oxidative stress, or apoptosis-can be confronted with deleterious effects on the other death pathways that also participate in the process of hypoxic-ischemic neuronal death. In the future, an appropriate combination of glutamate antagonists, antioxidants, and anti-apoptosis agents should be applied for maximal neuroprotection against hypoxic-ischemic injury.
Conclusion
Excitotoxicity, oxidative stress, and apoptosis comprise major routes of hypoxic-ischemic neuronal death. Each route is likely activated and propagated through selective transmembrane and intracellular signaling systems. Further understanding of the distinct and integrated mechanisms that lead to the three death routes is warranted for the efficient and secure treatment of hypoxic-ischemic brain injury.
